New Report on autosamplers market segmented into product & end user. Autosampler systems segment is further segmented into liquid chromatography (LC) autosampler and gas chromatography (GC) autosampler, while autosampler accessories are further segmented into vials, syringes, needles, and septum.
The global autosamplers market is projected to reach USD 1.14 Billion by 2022 from USD 0.79 Billion in 2017, at a CAGR of 7.6% during the forecast period. GC autosampler systems are further segmented into three types–liquid, headspace.
Download Study Papers of Autosamplers Market with 146 Pages, Profiling 15 Companies and Supported 82 Tables and 30 Figures at http://www.rnrmarketresearch.com/contacts/request-sample?rname=1226249 .
Autosamplers market is segmented into pharmaceutical & biopharmaceutical industry, oil & gas industry, food & bevarage industry, environmental testing industry, & end user segment. Pharmaceutical & biopharmaceutical segment is estimated to command largest share of global autosamplers market in 2017.
“LC autosampler systems segment is expected to be the fastest-growing segment during the forecast period.”
North America expected to command largest share of the market in 2017 due to increasing funds for R&D activities in healthcare industries, growing funding for environmental testing and cleanup activities in US, government initiatives to improve laboratory infrastructure, and government investments for environmental protection in Canada.
More Details and Information on Current Trends, Forecast, Analysis and Company Profiles at http://www.rnrmarketresearch.com/autosamplers-market-by-product-systems-liquid-chromatography-gc-liquid-headspace-all-in-one-accessories-syringe-needle-vial-septum-enduser-pharmaceutical-companies-oil-gas-food-beverage-envi-ts-to-2022-market-report.html .
Global autosamplers market was dominated by Agilent (US), Waters (US), Shimadzu (Japan), Thermo Fisher (US), and PerkinElmer (US). These companies accounted for a majority share of the global autosamplers market in 2016. The other players involved in this market include Merck (Germany), Bio-Rad (US), Restek (US), Gilson (US), JASCO (US), and SCION (US).
Advantages of autosamplers over manual injection systems, growing importance of chromatography in drug approvals, and increasing production of crude and shale oil are some of the key factors driving the growth of the market. The report covers autosamplers market across four major regions, namely, North America, Europe, Asia Pacific, & Rest of the World (RoW).
Reasons to Buy the Report:
- From an insights perspective, this research report has focused on various levels of analysis—market ranking analysis of top players and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the autosampler market, and high-growth regions and their drivers, restraints, challenges, and opportunities.
- The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
Get Discount on “Autosamplers Market by Product (Systems (Liquid Chromatography, GC (Liquid, Headspace, All-in-one)), Accessories (Syringe & Needle, Vial, Septum) & Enduser (Pharmaceutical companies, Oil & Gas, Food & Beverage, Environment testing) – Global Forecasts to 2022” Report at http://www.rnrmarketresearch.com/contacts/discount?rname=1226249
Breakdown of supply-side primary interviews:
- By Company Type – Tier 1 – 25%, Tier 2 – 30% and Tier 3 – 45%
- By Designation – – C level – 26%, Director level – 30%, Others – 44%
- By Region – North America – 34%, Europe – 26%, APAC – 23%, RoW – 17%
The report analyzes micromarkets with respect to their individual growth trends. The report forecasts the revenue of the market segments with respect to four main regions and respective countries. Growing importance of chromatography tests in drug approval process & increasing funds for R&D activities in pharmaceutical & biopharmaceutical industries are key factors driving growth of market.